This does not exclude that there is an effect of the VSMC EGFR in an HFD, as a major impact of angiotensin II in obesity is on the perfusion of the microvasculature [40] and these vessels were not the scope of our study. The gene discussed is EGFR; the disease is obesity due to melanocortin 4 receptor deficiency.